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Abstract 
Unbalanced chromosome translocations involving 
all or part of the whole long arm of chromosome 1 
and the short arms of acrocentric chromosomes are 
widely reported in human neoplasia. Among them, 
chromosome translocations between the long arm of 
chromosome 1 and chromosome 21 have been 
reported in patients with various conditions, 
including myeloid malignancies, acute 
lymphoblastic leukemia, multiple myeloma and 
lymphomas. 
KEYWORDS 
Gain of 1q; unbalanced translocations; gene 
overexpression; acrocentric chromosome. 
Clinics and pathology 
Disease 
Chronic and acute myeloid malignancies, acute 
lymphoblastic leukemia (ALL), multiple myeloma 
(MM) and various lymphoid neoplasms. 
Epidemiology 
There were 13 males and 10 females (1 unknown) 
aged 8 to 90 years old (median 65 years) in a group 
of patients with 1q11-12 translocations (Table 1). 
Patients with 1q25-32 translocations tended to be 
younger and included 6 males and 5 females aged 0 
to 72 years (median age 17 years), 2 of them were 










2 F/76 PV 46,XX,der(4)t(1;4)(q12;p16)/46,XX,der(21)t(1;21)(q12;p12) 
der(21)t(1;21)(q11-32;p11-13)  
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5 F/75 RARS 46,XX,del(20)(q11)/46,idem,der(21)t(1;21)(q12;p11) 
6 F/80 RAEB 46,XX,der(21)t(1;21)(q10;p10) 







ACUTE LYMHOBLASTIC LEUKEMIA 
8 M B-ALL 46,XY,der(19)t(1;19)(q23;p13)/46,idem,der(21)t(1;21)(q12;p13) 
9 F ALL 46,XX,der(19)t(1;19)(q23;p13)/46,idem,der(21)t(1;21)(q11;p11) 
10 M ALL 46,XY,del(13)(q1?2),der(21)t(1;21)(q12;p12) 
11   B-ALL 46,X?,der(1)t(1;19)(q23;p13),i(7)(q10),der(21)t(1;21)(q12;p13) 
12 M B-ALL 46,XY,del(6)(q13q23),der(19)t(1;19)(q23;p13)/46,idem,der(21)t(1;21)(q12;p11) 
MULTIPLE MYELOMA 
13 M MM 43,X,-Y,+1,der(1;15)(q10;q10),der(4)t(1;4)(q11;q35),-13,-14,der(21)t(1;21)(q11;p11),-22  /td> 
14 F MM 
44,X,-X,der(6)add(6)(p25)t(1;6)(q12;q12),?inv(7)(p14p22),del(8)(p11),-
13,del(20)(q12),der(21)t(1;21)(q10;p11) 


















NON HODGKIN LYMHOMA 
der(21)t(1;21)(q11-32;p11-13)  
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17 M/8 MBN 46,XY,der(8)t(7;8)(q21;q24)dup(7)(q21q36),der(14)t(8;14)(q24;q32),der(21)t(1;21)(q11;p13)  
18 M MBN 
42-47,XY,add(3)(q11),add(8)(q24),der(14)t(8;14)(q24;q32),t(14;18)(q32;q21),del(16)(q13),+20/42-
47, idem,der(21)t(1;21)(q11;p11)/47-48,idem,+X/47-48, idem,+7/49,idem,+X,+7 LN  
19 F FL 
49-50,X,del(X)(p21),dic(1;12)(?p21;q24),t(3;4)(q27;p13),+i(6)(p10),t(14;18)(q32;q21),i(17)(q10), 
+add(19)(q13),der(21)t(1;21)(q11;p11),+2mar LN  
20 F FL  
42-
54,XX,t(6;7)(p21;q22),+7,+der(7)t(6;7),t(8;14)(q24;q32),+11,+11,+12,+der(14)t(8;14),+21,der(21)t(
1;21)(q12;p13)x2 LN  
21 M DLBCL 
46,X,-
Y,add(1)(p32),dup(1)(q21q31),t(3;14)(q27;q32),add(8)(p11),del(9)(p11),der(21)t(1;21)(q12;p13), 
















HD 46,X,-Y,del(4)(q28),+8,add(9)(p24),der(14)t(1;14)(q11;p11),der(21)t(1;21)(q11;p11) LN  
Abbreviations: M, male; F, female; CMML, Chronic myelomonocytic leukemia; PV, Polycythemia vera; ET,  Essential 
thrombocythemia; MDS, Myelodysplastic syndrome; APL, Acute promyelocytic leukemia; RARS, Refractory anemia with 
ringed sideroblasts;  RAEB, Refractory anemia with excess of blasts; AML, Acute myeloid leukemia; ALL, Acute lymphoblastic 
leukemia/lymphoblastic lymphoma;  MM, Multiple myeloma; MBN, Mature B-cell neoplasm; LN, lymph node; FL, Follicular 
lymphoma; DLBCL, Diffuse large B-cell lymphoma; BL, Burkitt lymphoma/leukemia; PCL, Plasma cell leukemia; HD, Hodgkin 
disease.  
1. Amenomori et al., 1986; 2. Juneau et al., 1998; 3. Gangat et al., 2009; 4. Najfeld et al., 1994; 5. Huh et al., 2010; 6. 
Makishima et al., 2013; 7. Liu et al., 2007; 8. Raimondi et al., 1990; 9. Uckun et al., 1998; 10. Heerema et al., 2000; 11. Lu et 
al., 2002; 12. Bousquet et al., 2007; 13. Sawyer et al., 1998; 14. Sawyer et al., 1998; 15. Gabrea et al., 2008; 16. Sawyer et 
al., 2014; 17. Dayton et al., 1994; 18. Schmitz et al., 1997; 19. Roumier et al., 2000; 20. Katzenberger et al., 2004; 21. 
Ruminy et al., 2006; 22. Trcic et al., 2010; 23. Andreasson et al., 1998; 24. Stamatoullas et al., 2007 
 
 
  SEX/AGE DISEASE KARYOTYPE 
ACUTE MYELOID LEUKEMIA 
1 M/0 AML-M5 46,XY,der(1)t(1;1)(p36;q21)/45,idem,-Y/47,idem,+8/46,XY,der(21)t(1;21)(q21;p11) 
B-CELL ACUTE LYMHOBLASTIC LEUKEMIA 
2 M ALL 46,XY,der(21)t(1;21)(q21;p13)dup(1)(q21q32)  
3 F/0 ALL 47,XX,+X,t(11;19)(q23;p13),der(21)t(1;21)(q25;p11)  
4 M/11 ALL 46,XY,del(6)(q13q21),der(19)t(1;19)(q23;p13),der(21)t(1;21)(q21;p11)  
der(21)t(1;21)(q11-32;p11-13)  
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46,XY,der(8),der(9)x2,der(21),der(22)/46,idem,der(16)t(16;22)(q24;q11)   
T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA 
6 M/72 ALL 46,XY,der(21)t(1;21)(q25;p11)   
MULTIPLE MYELOMA 















NON HODGKIN LYMHOMA 








11 M/65 MF/SS  
45,XY,der(1)t(1;17)(p13;q21),t(2;5)(p14;q14),t(3;7)(p21;q35),t(4;9)(p?15;p?22),-5,-6,-9,-
11,del(12)(q22),-17,-19,add(19)(q13),der(21)t(1;21)(q32;p13),+5mar 
Abbreviations: M, male, f, female, BL, AML-M5, Acute monoblastic leukemia; ALL, Acute lymphoblastic  leukemia; MM, 
Multiple myeloma; Burkitt  lymphoma/leukemia; DLBCL, Diffuse  large cell lymphoma; MF/SS, Mycosis fungoides/Sezary 
syndrome.  
1. Chessells et al., 2002; 2. Raimondi et al., 1990; 3. Felix  et al., 1998; 4. Andersen et al., 2011; 5. Patterer et al., 2013; 6. 
Safavi et  al., 2015; 7. Gabrea et al., 2008; 8. Sawyer et al., 2014; 9. Fitzgerald et al.,  1984; 10. Gladstone et al., 1994; 11. 
Schlegelberger et al., 1994. 
 
Patients with centromeric 1q11-12 translocations 
were diagnosed mainly with myeloid malignancies 
and lymphomas  
  Myeloid malignancies in 7: 1 chronic 
myelomonocytic leukemia (CMML) (Amenomori et 
al., 1986), 1 myelodysplastic syndrome (MDS)/ 
acute promyelocytic leukemia (APL)-like leukemia 
(Najfeld et al 1994), 1 polycythemia vera (PV) 
(Juneau et al., 1998), 1 essential thrombocythemia 
(ET)  (Gangat et al., 2009), 1 refractory anemia with 
ringed sideroblasts (RARS) (Huh et al., 2010), 1 
refractory anemia with excess of blasts (RAEB) 
(Makishima et al., 2013) and 1 acute myeloid 
leukemia (AML) (Liu et al., 2007). 
  Acute lymphoblastic leukemia in 5 (Raimondi et 
al., 1990; Uckun et al., 1998; Heerema et al., 2000; 
Lu et al., 2002; Bousquet et al., 2007). 
  Multiple myeloma in 4 (Sawyer et al., 1998; Gabrea 
et al., 2008; Sawyer et al., 2014). 
  Various lymphoid malignancies in 7:  2 mature B-
cell neoplasm (MBN) (Schmitz et al., 1997; Dayton 
et al., 1994), 1 Burkitt lymphoma/leukemia (BL) 
(Trcic et al., 2010), 1 Plasma cell leukemia (PCL) 
(Andreasson et al., 1998), 2 follicular lymphoma 
(FL) (Roumier et al., 2000; Katzenberger et al., 
der(21)t(1;21)(q11-32;p11-13)  
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2004), 1 diffuse large B-cell lymphoma (DLBCL) 
(Ruminy et al., 2006) and 1 HD (Hodgkin disease) 
(Stam atoullas et al., 2007). 
 
 der(21)t(1;21) with 1q21-32 breakpoints  was less 
frequent and has been detected mainly in patients 
with ALL: 4 of them were diagnosed with B-cell 
ALL (Raimondi et al 1990; Felix et al., 1998; 
Andersen et al., 2011; Patterer et al., 2013) and 1 
patient with T-ALL (Safavi et al., 2015). In addition, 
there were sporadic cases with other malignancies: 1 
acute monoblastic leukemia (AML-M5) (Chessells 
et al., 2002), 1 diffuse large B-cell lymphoma 
(DLBCL), 1 Burkitt lymphoma/leukemia (BL) 
(Fitzgerald et al., 1984), 1 mycosis fungoides/Sezary 
syndrome (MF/SS) (Schlegelberger et al., 1994) and 
2 multiple myeloma patients (Gabrea et al., 2008; 
Sawyer et al., 2014). 
Prognosis 
Associated with poor-risk genetic features and/or 
complex karyotypes in the majority of described 
patients, indicative of chromosomal instability 
related to disease progression and therapy resistance. 
Cytogenetics 
 
Figure 1.  Partial karyotypes with der(21)t(1;21)(q11-12;p11-13) (A). Fluoresce in situ hybridization with LSI 
RUNX1/ RUNX1T1 probe (Vysis/Abott Molecular, US) revealing hybridization of RUNX1 probe to der(21) 
chromosome (green signal). (B). Hybridization with LSI 1p36/1q25 probe on metaphases and interphase cells 
showing the presence of extra green signal of  1q25 on der(21) chromosome and in interphase cells (green 
signal) (C). 
Cytogenetics morphological 
 der(21)t(1;21)(q11-12;p11-13)  has been detected 
as sole anomaly in 3 myeloproliferative disorders 
(Amenomori et al., 1986; Gangat et al., 2009; 
Makishima et al., 2013), found in association with 
trisomy 11 in MDS transforming to APL-like 
leukemia (Najfeld et al., 1994), del(20)(q11) in 
RARS (Huh et al., 2010) and additional 1q 
abnormalities in PV (Juneau et al., 1998) and AML 
patients (Liu et al., 2007). In patients diagnosed with 
ALL, there was a notable association with 
der(19)t(1;19)(q23;p13) as except 1 case with 
del(13q), in the remaining 4 ALL patients 
der(19)t(1;19)(q23;p13) was detected. Associated 
with t(8;14)(q24;q32) in 4 mature B-cell/Burkitt 
lymphoma/leukemia (Dayton et al., 1994; Schmitz et 
der(21)t(1;21)(q11-32;p11-13)  
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al., 1997; Katzenberger et al 2004; Trcic et al 2010) 
and with highly complex karyotypes in the 
remaining patients. 
In the group of  patients with 1q21-32 breakpoints 
, sole anomaly was detected only in 1 T-ALL (Safavi 
et al., 2015); found in association with 
t(11;19)(q23;p13) in an infant with B-ALL (Felix et 
al., 1998), der(19)t(1;19)(q23;p13) in the pediatric 
B-ALL (Andersen et al., 2011), t(8;22)(q24;q11) in 
1 B-ALL (Patterer et al., 2013) and (8;14)(q24;q32) 
in the BL patient (Fitzgerald et al., 1984). Found in 
the sideline with der(1)t(1;1)(p36;q21) and -Y/ +8 in 
infant with AML-M5 (Chessells et al., 2002) and as 
a part of complex karyotypes in the remaining 
patients. 
 
Figure 2.  Partial karyotypes with der(21)t(1;21)(q21;p11-13) (A). Fluorescence in situ hybridization with LSI 
1p36/1q25 probe (Vysis/Abott Molecular, US) on metaphase showing the extra 1q25 signal on der(21) 
chromosome and in interphase cells (B). 




Unbalanced 1q translocations to the short arms of 
acrocentric chromosomes are recurrent chromosome 
anomalies detectable in both hematologic neoplasms 
and lymphomas. Their main consequence is an extra 
copy of part of the long arm of chromosome 1 
resulting in gene dosage abnormalities. Unbalanced 
translocations involving 1q and an acrocentric 
chromosome typically do not involve key genes, but 
they have as main consequence gain of the long arm 
of chromosome 1. 1q gains typically involve large 
chromosome regions, therefore simultaneous 
overexpression of multiple genes that might 
cooperate in an additive or synergistic way is likely 
implicated in neoplastic processes. der(21)t(1;21) 
was apparently a late event in the majority of 
reported patients- occurring together with the well-
known primary abnormalities or as part of complex 
karyotypes, therefore representing clonal evolution 
change preceding or accompanying disease 
evolution. 
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